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The aim of this study was to determine whether scalp tenderness and photophobia, two
well-recognized symptoms of migraine, develop during the motion sickness induced
by optokinetic stimulation. To investigate whether motion sickness has a general inﬂu-
ence on pain perception, pain was also assessed in the ﬁngertips. After optokinetic
stimulation, nausea increased more and headache persisted longer in 21 migraine
sufferers than in 15 non-headache controls. Scalp tenderness increased during
optokinetic stimulation in nauseated subjects, and pain in the ﬁngertips increased
more and photophobia persisted longer in migraine sufferers than controls. These
ﬁndings suggest that the disturbance responsible for nausea also sensitizes trigeminal
nociceptive neurones or releases inhibitory controls on their discharge. A low nausea
threshold and a propensity for sensitization to develop rapidly in nociceptive pathways
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Introduction
Migraine sufferers appear to be more susceptible than
most other people to motion sickness. For example, over
50% of migraine patients surveyed by Kayan and Hood
(1) reported a history of motion sickness compared with
only 20% of tension headache sufferers. Motion sickness
is also strongly linked with migraine in children (2–4)
and university students (5).
Damage caused by episodic ischaemia of the labyrinth
during attacks of migraine might increase susceptibility
to motion sickness (6). In support of this view, vestibular
disturbances are common in migraine sufferers, particu-
larly when attacks are accompanied by vertebrobasilar
symptoms(1,7,8).However,othermechanismsmayalso
increase susceptibility to motion sickness. Migraine is
associated with recurrent abdominal pain in childhood
(9) and susceptibility to motion sickness and migraine
greatly increases the likelihood of vomiting after a mild
head injury (10). In addition, apomorphine provokes
nausea and vomiting more readily in adult migraine
sufferers than controls (11). Taken together, these
ﬁndings suggest that a low threshold for nausea and
vomiting contributes to the migraine predisposition and
might also increase susceptibility to motion sickness.
Motion sickness results from a sensory conﬂict or
‘neural mismatch’ between the visual system and the
vestibular and proprioceptive modalities (12, 13). In air
and sea sickness, symptoms develop when sensations
of movement do not match visual input. Symptoms of
motion sickness also develop during optokinetic stimu-
lation when the visual perception of movement does
not match vestibular and proprioceptive sensations
(e.g. while watching wide-screen movies) (14). Recog-
nition of a mismatch activates the brain stem nuclei
that mediate gastrointestinal disturbances and other
symptoms of motion sickness. Apart from nausea,
motion sickness is associated with upper abdominal
sensations, sleepiness, apathy, dizziness and headache,
that is, many of the symptoms of migraine. Thus, motion
sickness and migraine may share a ﬁnal common
pathway, possibly involving the brain stem nuclei that
mediate symptoms in these two conditions.
The main aim of the present study was to look for
further parallels between the symptoms of motion
sickness and those of migraine. In particular, the aim
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phobia, two well-recognized symptoms of migraine,
develop during the motion sickness induced by opto-
kinetic stimulation. As the vestibular apparatus is not
actively stimulated by the optokinetic procedure, vesti-
bulocochlear dysfunction could not be responsible for
symptoms of motion sickness during optokinetic stimu-
lation. Instead, any difference between migraine suf-
ferers and controls would be consistent with activation
of the ﬁnal common pathway responsible for symptoms
that develop in motion sickness and migraine.
The second aim was to investigate whether motion
sickness has a general inﬂuence on pain perception.
Burstein et al. (15, 16) reported that cutaneous allodynia
sometimes spread beyond the area of referred pain
during attacks of migraine to include the upper limbs.
They postulated that central sensitization could spread
from second order trigeminal neurones in the brain stem
to third order nociceptive neurones in the thalamus.
Alternatively, allodynia extending beyond the area of
referred pain could result from failure of central pain-
modulating mechanisms. Even during the headache-free
interval, modulation of nociceptive visceral signals
may be disrupted in migraine sufferers. For example,
Nicolodi et al. (17) reported that venous distension and
injection of hypertonic saline into the antecubital vein
provoked pain more readily in migraine sufferers than
controls. Therefore, it was hypothesized that sensitivity
to pain in the ﬁngertips would increase after optokinetic
stimulation in migraine sufferers.
Method
Subjects
The migraine sample consisted of 21 women aged
between 18 and 50 years (mean age 27¡10 years) who
met International Headache Society criteria (18) for
migraine with aura (seven subjects) or migraine without
aura (14 subjects). Headaches recurred, on average, at
least once per month. Eight subjects took ergotamine
or sumatriptan to relieve their attacks, whereas the
remainder took only analgesic medication. Six subjects
had experienced a migraine within the past week. How-
ever, only one subject had taken ergotamine during
this period and none of the 21 subjects took migraine
medication prophylactically. The control group con-
sisted of 15 women aged between 18 and 38 years (mean
age 26¡7 years) who did not suffer from migraine and
who only rarely experienced other forms of mild
headache. Three of these women reported a history of
migraine in one of their ﬁrst-degree relatives. However,
a family history of migraine was not an exclusionary
criterion for controls because a similar history was
obtained in only 15 of the 21 migraine sufferers.
Subjects were recruited by advertisement from stu-
dents and staff of Murdoch University and were paid
$10 for participating. Each gave their informed consent
for the procedures, which were approved by the local
ethics committee.
Procedure
Scalp tenderness
Scalp tenderness was assessed using an algometer with
a 2-mm diameter hemispherical probe tip. To induce
sensations of mild to moderate pain, the probe tip
was applied to each side of the forehead at four
pressures (85 gm, 170 gm, 255 gm and 340 gm).
Pressure was applied for 5 s to discrete sites 1–4 cm
above the eyebrow and 1–4 cm from the midline. The
order of stimulation (in terms of site and pressure)
varied randomly within and between subjects from one
test to the next. After each stimulus, the subject rated
pain intensity verbally on a scale ranging from 0 (not
painful) to 10 (extremely painful). The experimenter
recorded this rating and then applied the next stimulus.
Pain elsewhere
The same procedure was used to assess pain sensations
in the ﬁngertips. The probe tip of the algometer was
applied close to the join between the ﬁngernail and
ﬁngertip on each ﬁnger of each hand (excluding the
thumb) at one of four pressures (85 gm, 170 gm, 255 gm
and 340 gm; stimulus duration 5 s). The order of
stimulation (in terms of ﬁngertip and pressure) varied
randomly within and between subjects from one test
to the next.
Photophobia
Before investigating sensitivity to light, the subject
adapted to darkness in a small room for several minutes.
She was then asked to look at the light emitted from a
50-watt halogen globe positioned 40 cm in front of her
eyes. The power supply of the globe was regulated to
produce an illumination of 1000 lux for 2 s (measured at
the position of the subject’s eyes by a Gossen Proﬁsix
lightmeter with a Proﬁlux attachment). The subject rated
glare from 0 (no glare) to 10 (the most dazzling light she
had ever seen), and pain from 0 (not painful) to 10
(extremely painful). The light was presented three times
at 30-s intervals.
Optokinetic stimulation
To induce symptoms of motion sickness, the subject sat
on a stationary chair with her head and shoulders inside
a drum 50 cm in diameter, 70 cm in height and painted
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stripes (19). The drum revolved 10 times per min for
15 min, or until the subject thought that she was about
to vomit. In susceptible subjects, the moving stripes
appeared to slow down or stop during drum rotation
whereas the stationary chair the subject was sitting on
appeared to spin. The mismatch between the visual
illusion of movement and opposing vestibular and
proprioceptive sensations induced motion sickness.
Immediately after the optokinetic stimulation, the
subject rated symptoms of motion sickness (dizziness,
nausea, body warmth, sweating and headache) on
scales where 0 corresponded to ‘none’ and 10 to
‘extreme’. Residual symptoms of motion sickness were
rated 30 min later.
Test sequence
Scalp tenderness, photophobia and sensitivity to
mechanical stimulation of the ﬁngertips were assessed
before and shortly after optokinetic stimulation, and
after 30 min of recovery from optokinetic stimulation.
Photophobia was assessed before scalp tenderness and
pain sensations in the ﬁngertips on 50% of occasions.
In addition, pain sensations were assessed in the ﬁnger-
tips before pressure was applied to the forehead on 50%
of occasions.
Reliability of repeated pain assessments
Pain sensitivity was assessed on another occasion in 16
migrainesufferersand12controls.Onthisoccasion,scalp
tenderness, photophobia, and sensitivity to mechanical
stimulation of the ﬁngertips were assessed three times at
30-min intervals, in the absence of optokinetic stimula-
tion. In seven cases this session preceded the session that
included optokinetic stimulation.
Statistical approach
As preliminary analyses indicated that ﬁndings did
not differ between subjects with or without a history
of migraine aura, migraine sufferers formed a single
category in subsequent analyses. Symptoms of motion
sickness (dizziness, nausea, body warmth, sweating and
headache) were compared between migraine sufferers
and controls in a multivariate analysis of variance with
one repeated measures factor (immediately after opto-
kinetic stimulation vs. 30 min later). Ratings of scalp
tenderness and pain sensations in the ﬁngertips were
averaged over the four application pressures to mini-
mize ﬂoor and ceiling effects. Changes in these scores
and in mean ratings of glare and light-induced pain were
investigated in 2 3 3 [group (migraine, control) 3 block
(before optokinetic stimulation, after optokinetic
stimulation, 30 min later)] analyses of variance. The
multivariate solution was used for the repeated mea-
sures factor. Rating changes over repeated assessments,
and in relation to the intensity of nausea and head-
ache after optokinetic stimulation, were investigated
in similar analyses.
Results
Symptoms of motion sickness
Two of the 15 controls and ﬁve of the 21 migraine
sufferers withdrew from the optokinetic drum before
the full 15 min of stimulation because they thought that
they were about to vomit (difference between groups
not signiﬁcant). In combination, symptoms of motion
sickness did not differ consistently between migraine
sufferers and controls (multivariate F(5,30)=1.16,
not signiﬁcant). Nevertheless, nausea was greater
in migraine sufferers (F(1,34)=5.95, P<0.05) (Fig. 1).
Symptoms subsided during the 30-min recovery period
(multivariate F(5,30)=35.6, P<0.001).
Headache developed during optokinetic stimulation
in 10 of 15 controls and 14 of 21 migraine sufferers. Most
subjects described a dull ache across the forehead, in the
temples or behind the eyes, but three migraine sufferers
and one control reported that the headache was more
intense on one side of the head. The headache was
throbbing in three migraine sufferers and two controls
(neither with a family history of migraine). Only one
of the three controls with a family history of migraine
reported any headache after optokinetic stimulation.
This subject described a mild non-throbbing left-sided
ache (rated 1 out of 10 in terms of intensity).
Headache ratings did not differ consistently between
groups shortly after optokinetic stimulation. However,
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Figure 1 Symptoms of motion sickness in migraine sufferers
(& n=21) and controls (u n=15) (* rating greater in migraine
sufferers than controls, P<0.05). In Figs 1, 2, 3 and 4 error bars
represent standard errors.
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than controls 30 min later (2.8¡0.5 vs. 1.1¡0.4, t(34)=
2.25, P<0.05). Headache straight after optokinetic
stimulation was greatest in subjects who reported most
light-induced pain at baseline (r(28)=0.57, P<0.001) and
after optokinetic stimulation (r(28)=0.53, P<0.01), but
was unrelated to ratings of glare, scalp tenderness or
pain in the ﬁngertips either before or after optokinetic
stimulation.
Scalp tenderness
Ratings of scalp tenderness increased to a similar extent
in migraine sufferers and controls after optokinetic
stimulation, and returned towards baseline 30 min later
(main effect for block, F(2,33)=11.87, P<0.001) (Fig. 2a).
Twenty-one subjects developed severe nausea (a rating
of 6 or more) during optokinetic stimulation, whereas 15
subjects had no nausea or reported only mild nausea (a
rating of 5 or less). As shown in Fig. 2(b), the increase in
scalp tenderness after optokinetic stimulation was more
pronounced in severely nauseated subjects than in those
with mild nausea (nausea–block interaction, F(2,33)=
5.40, P<0.01). Scalp tenderness was unrelated to head-
ache intensity. In the absence of optokinetic stimulation,
ratings of scalp tenderness averaged 4.3 (mildly to
moderately painful) and did not change signiﬁcantly
over three measurements repeated at 30-min intervals.
Pain sensations in the ﬁngertips
Pain ratings increased in migraine sufferers but not
in controls after optokinetic stimulation (group–block
interaction, F(2,33)=5.36, P<0.01) and returned
towards baseline 30 min later (Fig. 3). The increase in
pain ratings after optokinetic stimulation was unrelated
to the intensity of nausea or headache. In the absence of
optokinetic stimulation, pain ratings decreased from 4.3
to 3.9 over the three repeated measurements in both
groups (main effect for block, F(2,25)=3.56, P<0.05).
Photophobia
Light-induced pain increased slightly in both groups
after optokinetic stimulation. During the 30-min
recovery period, light-induced discomfort persisted in
migraine sufferers but decreased in controls (group–
block interaction, F(2,27) = 3.87, P<0.05) (Fig. 4a). the
increase in light-induced pain after optokinetic stimula-
tion was unrelated to the intensity of nausea or head-
ache. In the absence of optokinetic stimulation, ratings
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Figure 2 Ratings of tenderness in response to mechanical
stimulation of the forehead in (a) migraine sufferers (&) and
controls (u), and (b) subjects who were mildly (u) or severely
nauseated (&) after optokinetic stimulation.
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Figure 3 Pain ratings in response to mechanical stimulation of
the ﬁngertips in migraine sufferers (&) and controls (u).
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repeated three times (change over all three measure-
ments, F(2,25)=2.79, P<0.1; decrease from the ﬁrst to
the second measurement, F(1,26)=5.58, P<0.05).
Glare ratings did not change in either group after
optokinetic stimulation (Fig. 4b), or after repeated
measurements in the absence of optokinetic stimulation
(mean rating 7.1). Glare ratings were unrelated to the
intensity of nausea or headache.
Discussion
Migraine sufferers generally have a low tolerance for
bright light and loud noise (20–25), and a dull back-
ground headache persists between intermittent attacks
of migraine in around 20% of patients who attend
specialist treatment centres (26). These observations
suggest that some of the disturbances responsible for
symptoms of migraine persist subclinically and could
increase the likelihood of recurrent attacks.
In the present study, nausea increased more and
headache persisted longer after optokinetic stimula-
tion in migraine sufferers than controls. Scalp tenderness
increased during optokinetic stimulation in nauseated
subjects, and pain sensitivity in the ﬁngertips increased
more and light-induced pain persisted longer in
migraine sufferers than controls. In sum, optokinetic
stimulation provoked symptoms associated with
migraine, particularly in subjects with a migraine
predisposition.
Symptoms of motion sickness
Ratings of nausea were greater in migraine sufferers
than controls after optokinetic stimulation. As the ves-
tibular apparatus was not directly stimulated during the
optokinetic procedure, this ﬁnding is unlikely to be due
to vestibulocochlear dysfunction in migraine sufferers.
The sensory conﬂict responsible for generating symp-
toms of motion sickness during optokinetic stimulation
could arise in the vestibular nuclei, because vestibular
neurones encode moving visual ﬁelds in the absence of
rotation (27). However, vestibular neurone dysfunc-
tion is unlikely to be the source of increased nausea
in migraine sufferers because other symptoms of motion
sickness (dizziness, body warmth and sweating) did
not differ between the two groups. As nausea precedes
vomiting, it seems plausible that nausea is associated
with the prodromal activation of neurones in the nucleus
tractus solitarius that coordinate emesis (28); in addition,
higher centres (e.g. the inferior frontal gyrus of the
cerebral cortex) may bring sensations of gastrointestinal
discomfort into conscious awareness (29). The present
ﬁndings support the view that neurones involved
in encoding gastrointestinal disturbances are more
responsive than normal in migraine sufferers (10, 11).
Migraine and tension headache appear to form the
extremes in a continuum of headache activity (30). In
the middle of this continuum are patients who report a
persistent low-grade or ﬂuctuating headache associated
sporadically with migrainous symptoms such as nausea
and dizziness (30), thus resembling the headache that
developed during optokinetic stimulation. A headache
more closely resembling migraine appears to develop
during sea sickness (31), presumably because the
severity of the motion sickness intensiﬁes the headache.
Plasma levels of calcitonin gene-related peptide are
elevated in a subgroup of chronic tension headache
sufferers with throbbing headache both during episodes
of headache and interictally (32), suggesting that this
form of headache is related to migraine. Unfortunately,
the incidence of throbbing headache was too low to
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subjects with throbbing headaches differed from
the symptom proﬁle associated with constant, dull
headaches.
Headache developed to the same extent in migraine
sufferers and controls after optokinetic stimulation.
However, the persistence of the headache in migraine
sufferers suggests that a mechanism that suppresses
head pain may not work efﬁciently in people with a
migraine predisposition. Susceptibility to the headache
induced by optokinetic stimulation in non-headache
controls did not seem to depend on a family history of
migraine, although the small number of subjects in this
category obviously limits generalizations about this
observation.
Scalp tenderness
Burstein et al. (33) postulated that central trigeminal
neurones that receive convergent input from meningeal
perivascular ﬁbres and the facial skin become sensitized
during migraine. Burstein et al. (15, 16) subsequently
demonstrated that cutaneous allodynia to thermal and
mechanical stimulation developed within and outside
the area of referred pain during migraine attacks. In
the present study, scalp tenderness developed acutely
during motion sickness in association with nausea
rather than headache. This raises the possibility that
the disturbance responsible for nausea also sensitizes
central trigeminal neurones, or releases inhibitory
inﬂuences on trigeminal discharge.
Neurones in the medullary nuclei of the solitary tract
respond to a range of inputs that elicit nausea and
vomiting, including noxious gastric distension and
administration of emetic drugs (34, 35). Some neurones
in this region receive convergent signals from vestibular
nuclei and gastrointestinal afferents, and could mediate
motion sickness-related vomiting (28, 36). Importantly,
subcutaneous injection of formalin into the vibrissal pad
of awake rats and electrical stimulation of trigemino-
vascular afferents in the superior sagittal sinus of
monkeys activates nuclei in the caudal part of the
solitary tract (37, 38). Furthermore, axons project from
the nucleus tractus solitarius towards the dorsal
medullary raphe and the trigeminal nucleus caudalis
in humans (39). Therefore, an anatomical substrate
exists for reciprocal communication between the nucleus
tractus solitarius and the trigeminal nuclei that mediate
headache and facial pain. It is tempting to speculate
that the increase in scalp tenderness in nauseated
subjects during optokinetic stimulation was due to a
direct excitatory inﬂuence of solitary tract nuclei on the
trigeminal nucleus caudalis, or to a disruptive inﬂu-
ence of solitary tract nuclei on pain modulating circuits
in the medulla. If this is the case, activity in nuclei of
the solitary tract may help to sensitize central trigeminal
neurones which, in turn, mediate scalp tenderness and
other symptoms of migraine. Additional mechanisms
appear to maintain central sensitization because scalp
tenderness persists for several days after attacks of
migraine, when other symptoms have resolved (40).
Pain in the ﬁngertips
Sensitivity to pain in the ﬁngertips increased in migraine
sufferers but not controls after optokinetic stimulation
and was unrelated to the intensity of nausea or head-
ache. Burstein et al. (15, 16) speculated that sensitization
could spread from trigeminal nuclei during attacks
of migraine to involve nociceptive neurones in the
thalamus. Alternatively, disruption to pain modulating
systems (responsible, for example, for stress-induced
analgesia or diffuse noxious inhibitory controls) could
release inhibitory inﬂuences on pain sensations. The
inﬂuence of pain modulating systems on hyperalgesia
during motion sickness requires further investigation.
Photophobia
Painful stimulation of the face intensiﬁes visual dis-
comfort in migraine sufferers (21, 22). Conversely, bright
light may increase scalp tenderness (22, 41) and usually
aggravates headache. An escalating interaction between
sensory stimulation and head pain could explain why
bright lights, loud noise and strong smells can trigger
attacks of migraine. In the present study, the strong
association between light-induced pain at baseline and
headache intensity after optokinetic stimulation suggests
that the prior presence of photophobia increased the
likelihood of headache.
In previous studies, photophobia persisted to some
extent in migraine sufferers during the headache-free
interval (20–25, 41). In the present study, however,
ratings of glare and light-induced pain initially were
similar in migraine sufferers and controls. Headache
susceptibility on the day of investigation probably was
lower in the present migraine sample than in studies
where subjects were recruited from specialist treatment
clinics, perhaps accounting for low ratings of light-
induced pain at baseline. Nevertheless, the persistence of
light-induced pain in migraine sufferers after optokinetic
stimulation suggests that photophobia developed read-
ily. In contrast to ratings of light-induced pain, glare
ratings did not change after optokinetic stimulation and
were similar in migraine sufferers and controls. Glare
ratings do not increase during headache (20), implying
that photophobia in migraine is linked more closely with
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perception.
Implications for treatment of migraine
Various forms of sensory stimulation appear to interact
with the sensitized trigeminal system during attacks
of migraine to produce unpleasant sensations such as
photophobia. As certain symptoms of migraine persist
subclinically during the headache-free interval, tri-
geminal sensitization may also persist subclinically
between attacks or develop rapidly to minor provo-
cations. If so, treatments that reduce or prevent
trigeminal sensitization should also reduce the fre-
quency of recurrent attacks of migraine. As trigeminal
stimulation increases light-induced pain (21, 22), photo-
phobia might serve as a useful marker of trigeminal
sensitization and current susceptibility to headache.
The susceptibility of migraine sufferers to nausea
during optokinetic stimulation suggests that a persistent
subclinical disturbance, presumably originating in brain
stem nuclei, increases susceptibility to motion sickness
and migraine. During migraine, antiemetics such as
domperidone alleviate gastrointestinal disturbances and
sensitivity to light and sound but are less effective at
relieving headache than treatments such as sumatriptan
(42). Nevertheless, when combined with paracetamol,
domperidone appears to be as effective as orally admin-
istered sumatriptan in relieving headache and gastro-
intestinal symptoms (43). Unfortunately, side-effects
currently limit the utility of employing antiemetics
prophylactically (42). However, domperidone is more
effective than placebo at preventing attacks of migraine
if taken during the migraine prodrome (44, 45), suggest-
ing that nausea develops early in the attack and initiates
other symptoms.
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